Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

What Does Pfizer's 2012 Earnings Tell Us About Its Operations?
Seeking Alpha
Wednesday, February 13, 2013 - 10:26am
tags:
Pfizer, earnings
Allergan and MAP: Pharma Buyout With a 60% Premium
Motley Fool
Wednesday, February 13, 2013 - 10:24am
tags:
Allergan, MAP Pharmaceuticals, M&A
Bayer Seeks Riociguat Approval
Yahoo/Zacks
Wednesday, February 13, 2013 - 10:22am
tags:
Bayer, Riociguat, PAH, pulmonary arterial hypertension
Five Super Ideas in the Healthcare Sector
Motley Fool
Wednesday, February 13, 2013 - 10:21am
tags:
Eli Lilly, Merck, Forest Labs, Regeneron, Seattle Genetics
Agilent forges diagnostic test partnership with Pfizer; follows January deal with Eli Lilly
Yahoo/AP
Wednesday, February 13, 2013 - 10:20am
tags:
Agilent, Pfizer, Eli Lilly, cancer diagnostics, Dako
Can Johnson & Johnson Hold Its Ground in the Multiple Myeloma Market?
Motley Fool
Wednesday, February 13, 2013 - 10:16am
tags:
JNJ, Multiple Myeloma, Velcade, Celgene, Revlimid, AbbVie, ONYX Pharmaceuticals, Bristol-Myers Squibb
Slow approvals put India's drug trials industry at risk
Reuters
Wednesday, February 13, 2013 - 10:14am
tags:
drug approvals, clinical trials, India
Pharmacyclics Gains ‘Breakthrough’ Status for Cancer Drug
Bloomberg
Wednesday, February 13, 2013 - 10:11am
tags:
Pharmacyclics, ibrutinib, JNJ
Promising Italian Biotech With An Upcoming CHMP Meeting
Seeking Alpha
Tuesday, February 12, 2013 - 12:25pm
tags:
CHMP, Gentium
Shire to Forest on Deal List for AstraZeneca: Real M&A
Bloomberg
Tuesday, February 12, 2013 - 12:13pm
tags:
Shire, Forest Labs, AstraZeneca, M&A
Dynavax Options Trade for Heplisav FDA Approval Decision
TheStreet.com
Tuesday, February 12, 2013 - 12:12pm
tags:
FDA, Dynavax, Heplisav
Alimera Sciences: A Sleeping Giant
Seeking Alpha
Tuesday, February 12, 2013 - 12:06pm
tags:
Alimera, diabetic macular edema, flucinolone ocular implant
GSK, others weigh $3-4 billion deal for Brazilian drugmaker: sources
Reuters
Tuesday, February 12, 2013 - 12:04pm
tags:
GSK, M&A, Brazil, Ache Laboratorios Farmaceuticos
Update on Lilly's Tabalumab
Yahoo/Zacks
Tuesday, February 12, 2013 - 11:12am
tags:
Eli Lilly, tabalumab, rheumatoid arthritis
Will Johnson & Johnson Win Approval for Its Diabetes Drug?
Motley Fool
Tuesday, February 12, 2013 - 11:00am
tags:
JNJ, diabetes, Invokana
Why Raptor Could Run Up To Its PDUFA
Seeking Alpha
Tuesday, February 12, 2013 - 10:59am
tags:
Raptor Pharmaceuticals, Mylan, nephropathic cystinosis, RP103
Can This Celgene Drug Defy the Patent Cliff?
Motley Fool
Tuesday, February 12, 2013 - 10:57am
tags:
patents, Celgene, myelodysplastic syndrome, Vidaza
Eli Lilly says will keep animal health business, Reuters reports
Yahoo/Fly on the Wall
Tuesday, February 12, 2013 - 10:55am
tags:
animal health, Eli Lilly, Elanco
Amgen, UCB halt testing of drug for fracture healing, but continue testing for osteoporosis
Yahoo/AP
Tuesday, February 12, 2013 - 10:55am
tags:
Amgen, UCB Pharmaceuticals, fractures, osteoporosis, romosozumab
Reckitt in $482 mln deal to sell Bristol drugs in LatAm
Reuters
Tuesday, February 12, 2013 - 10:54am
tags:
Reckitt Benckiser, Latin America, M&A, Bristol-Myers Squibb, OTC

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.